Diagnosis → Ophthalmology

Scleritis

Inflammation of the sclera with or without adjacent corneal/uveal involvement:

  • Subtypes:

    • Anterior or posterior

    • Diffuse, nodular, or necrotizing

Also known as: Logaditis, Scleral inflammation, Sclerotitis

Etiology

Cause [fup][zth]

Pathophysiology [fup]

  1. Trigger

    • Systemic autoimmune disease

    • Local ocular trigger (surgery/trauma/infection)

  2. Scleral immune activation

    • Inflammatory cell infiltration and cytokine-mediated tissue injury

    • In necrotizing forms: vasculitis of deep episcleral/scleral vessels

  3. Structural damage and extension

    • Scleral edema → severe ocular pain and deep injection

    • Scleral thinning/necrosis

    • Spillover to cornea/uvea → keratitis/uveitis, secondary glaucoma

  4. Vision loss from keratitis, uveitis, glaucoma, cataract, retinal/choroidal complications

  5. Necrotizing and posterior scleritis cases pose a higher risk of visual loss

Complications [zth][kvi]

Epidemiology

Incidence per 100.000 [fup][qun][kvi][sr2]

Default

Epidemiology chart for Incidence

Symptoms & findings

Symptoms

Blurred vision, Lacrimation, Photophobia, Red eye

Clinical findings

None listed.

Anamneses

None listed.

Localized findings

Pain
Radiates
Eyes
Onset
Subacute (hours)Gradual (days)
Pattern
ConstantIncreasing
Provoked by
Sudden movementPalpation
Quality
SharpStabbingCuttingBurningAching
Severity
Moderate (4-7)Severe (8-10)

Approach

Treatment

  1. Associated disease-specific treatment [zth]

    • Rosacea

    • Gout

    • Atopy

    • Infection: Topical (and systemic) antimicrobial therapy

  2. Noninfectious scleritis:

    • Topical therapy:

      • Topical corticosteroid eyedrops

      • Periorbital and subconjunctival steroid injection (often insufficient)

    • Systemic treatment:

      • 1st line: Systemic NSAIDs

        • Indomethacin 50 mg x 3 per day

        • Ibuprofen 600 mg x 3 per day

        • Naproxen 500 mg x 2 per day

      • 2nd line: Corticosteroids

        • Prednisone 1 mg/kg/day (60-80 mg/day)

        • Dose continued until one month after the resolution of scleritis

      • 3rd line: Immunomodulatory drugs:

        • Methotrexate 7.5-25 mg PO/IM once a week

        • Azathioprine 1-2.5 mg/kg/day PO

        • Cyclophosphamide 1.5-3 mg/kg/day PO

        • Mycophenolate mofetil 1 g PO bid

        • Infliximab 3-5 mg/kg IV q6-8wk

        • Adalimumab 40 mg every 2 weeks

  3. Surgery may rarely be required to preserve the integrity of the globe in cases of pending perforation

    • Scleral grafts from fresh donor sclera or glycerin-preserved sclera

Differential diagnoses

Conjunctivitis, Episcleritis, Foreign body, Glaucoma, Herpes zoster, Iridocyclitis, Keratitis, Periorbital cellulitis, Rosacea, Squamous cell carcinoma, Subconjunctival hemorrhage


References

[1] Lagina A, Ramphul K. Scleritis. [Updated 2023 Jun 26]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK499944/

[2] https://emedicine.medscape.com/article/1228324 (6th september 2026)

[3] Xu TT, Reynolds MM, Hodge DO, Smith WM. Epidemiology and Clinical Characteristics of Episcleritis and Scleritis in Olmsted County, Minnesota. Am J Ophthalmol. 2020 Sep;217:317-324.

[4] Homayounfar G, Nardone N, Borkar DS, Tham VM, Porco TC, Enanoria WT, Parker JV, Vinoya AC, Uchida A, Acharya NR. Incidence of scleritis and episcleritis: results from the Pacific Ocular Inflammation Study. Am J Ophthalmol. 2013 Oct;156(4):752-8.

[5] Braithwaite T, Adderley NJ, Subramanian A, Galloway J, Kempen JH, Gokhale K, Cope AP, Dick AD, Nirantharakumar K, Denniston AK. Epidemiology of Scleritis in the United Kingdom From 1997 to 2018: Population-Based Analysis of 11 Million Patients and Association Between Scleritis and Infectious and Immune-Mediated Inflammatory Disease. Arthritis Rheumatol. 2021 Jul;73(7):1267-1276.

Scroll to top